Stephen G Swisher Selected Research

Deoxyglucose (2 Deoxy D glucose)

10/2022	Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients.
6/2006	Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen G Swisher Research Topics

Disease

133	Neoplasms (Cancer) 11/2022 - 01/2002
63	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2003
57	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2002
52	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2002
46	Adenocarcinoma 11/2021 - 12/2004
27	Carcinoma (Carcinomatosis) 10/2022 - 04/2003
25	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2002
8	Malignant Mesothelioma 01/2022 - 05/2005
8	Pathologic Complete Response 01/2021 - 12/2005
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 12/2004
5	Infections 02/2018 - 08/2005
5	Melanoma (Melanoma, Malignant) 05/2005 - 04/2002
4	Pneumonia (Pneumonitis) 01/2021 - 03/2008
4	Colorectal Neoplasms (Colorectal Cancer) 05/2020 - 12/2012
4	Carcinogenesis 01/2019 - 01/2011
4	Breast Neoplasms (Breast Cancer) 08/2011 - 02/2002
3	Hemorrhage 01/2021 - 12/2017
3	Disease Progression 01/2021 - 11/2014
3	Leukemia 11/2017 - 01/2015
3	Anastomotic Leak 04/2014 - 01/2002
3	Sarcoma (Soft Tissue Sarcoma) 05/2011 - 11/2005
3	Barrett Esophagus (Barrett's Esophagus) 12/2009 - 02/2007
2	Esophageal Squamous Cell Carcinoma 12/2022 - 02/2007
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 02/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2020 - 12/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2020
2	Lymphatic Metastasis 01/2020 - 02/2012
2	Adenocarcinoma of Lung 01/2019 - 12/2013
2	Wounds and Injuries (Trauma) 11/2016 - 02/2002

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2008
19	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
12	eIF-2 Kinase (eIF 2 Kinase)IBA 01/2020 - 04/2002
7	PlatinumIBA 02/2018 - 05/2005
6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
6	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
6	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2005 - 04/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2010
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2004
4	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2017
4	Biological ProductsIBA 01/2020 - 03/2008
4	ParaffinIBA 01/2018 - 04/2009
4	1- ((3- chlorophenyl)methyl)- 1H- indole- 3- carbinolIBA 11/2017 - 05/2012
4	ErbB Receptors (EGF Receptor)IBA 07/2015 - 02/2007
4	E2F1 Transcription FactorIBA 03/2010 - 04/2003
3	Hematoxylin (Haematoxylon)IBA 11/2021 - 01/2007
3	Eosine Yellowish-(YS) (Eosin)IBA 11/2021 - 01/2007
3	Oxygen (Dioxygen)IBA 09/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2006
3	Indicators and Reagents (Reagents)IBA 08/2020 - 09/2006
3	CytokinesIBA 01/2020 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2009
3	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 03/2006
3	LigandsIBA 01/2018 - 01/2017
3	Formaldehyde (Formol)FDA Link 01/2018 - 04/2009
3	Messenger RNA (mRNA)IBA 01/2018 - 09/2009
3	AntigensIBA 01/2017 - 11/2007
3	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 05/2012
3	Cyclin D1IBA 01/2011 - 02/2007
3	InterferonsIBA 02/2009 - 02/2002
3	LuciferasesIBA 08/2005 - 04/2003
2	NivolumabIBA 11/2022 - 01/2021
2	IpilimumabIBA 11/2022 - 01/2021
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2022 - 06/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2020
2	Dasatinib (BMS 354825)FDA Link 10/2020 - 12/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020 - 10/2004
2	B7-H1 AntigenIBA 01/2020 - 01/2019
2	Therapeutic UsesIBA 01/2020 - 01/2017
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2018
2	Capecitabine (Xeloda)FDA Link 11/2019 - 01/2017
2	NucleotidesIBA 01/2019 - 01/2019
2	EnzymesIBA 01/2019 - 01/2013
2	Thioredoxin-Disulfide ReductaseIBA 01/2019 - 01/2019
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 02/2009
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 01/2019
2	Auranofin (Ridaura)FDA Link 01/2019 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018 - 09/2014
2	AntibodiesIBA 01/2017 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 08/2005
2	taxaneIBA 01/2017 - 12/2003
2	Histones (Histone)IBA 01/2017 - 12/2009

Therapy/Procedure

99	Therapeutics 12/2022 - 01/2002
34	Radiotherapy 10/2020 - 01/2002
31	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
31	Neoadjuvant Therapy 01/2022 - 02/2002
26	Chemoradiotherapy 11/2019 - 09/2003
22	Esophagectomy 12/2022 - 01/2002
12	Induction Chemotherapy 01/2019 - 09/2003
9	Immunotherapy 01/2021 - 02/2002
6	Aftercare (After-Treatment) 10/2022 - 10/2017
6	Pneumonectomy (Lung Volume Reduction) 01/2022 - 03/2004
6	Metastasectomy 09/2019 - 09/2009
6	Length of Stay 01/2018 - 01/2002
4	Proton Therapy 10/2020 - 08/2011
3	Thoracotomy 09/2020 - 05/2010
3	Operative Surgical Procedures 01/2020 - 12/2003
3	Adjuvant Chemotherapy 01/2019 - 07/2010
2	Precision Medicine 05/2020 - 07/2015
2	Stents 01/2020 - 12/2017
2	Perioperative Period 02/2018 - 09/2002